| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances
|
Sfriso, Paolo
|
|
2018
|
78 |
12 |
p. 1187-1195
|
article
|
| 2 |
Alectinib: A Review in Advanced, ALK-Positive NSCLC
|
Paik, Julia
|
|
2018
|
78 |
12 |
p. 1247-1257
|
article
|
| 3 |
Correction to: Andexanet Alfa: First Global Approval
|
Heo, Young-A
|
|
2018
|
78 |
12 |
p. 1285
|
article
|
| 4 |
Correction to: Anlotinib: First Global Approval
|
Syed, Yahiya Y.
|
|
2018
|
78 |
12 |
p. 1287
|
article
|
| 5 |
Danoprevir: First Global Approval
|
Markham, Anthony
|
|
|
78 |
12 |
p. 1271-1276
|
article
|
| 6 |
Danoprevir: First Global Approval
|
Markham, Anthony
|
|
2018
|
78 |
12 |
p. 1271-1276
|
article
|
| 7 |
Encorafenib and Binimetinib: First Global Approvals
|
Shirley, Matt
|
|
2018
|
78 |
12 |
p. 1277-1284
|
article
|
| 8 |
Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
|
Dhillon, Sohita
|
|
2018
|
78 |
12 |
p. 1259-1270
|
article
|
| 9 |
Metastatic Melanoma: Recent Therapeutic Progress and Future Perspectives
|
Malissen, Nausicaa
|
|
|
78 |
12 |
p. 1197-1209
|
article
|
| 10 |
Metastatic Melanoma: Recent Therapeutic Progress and Future Perspectives
|
Malissen, Nausicaa
|
|
2018
|
78 |
12 |
p. 1197-1209
|
article
|
| 11 |
Perioperative Use of Intravenous Lidocaine
|
Beaussier, Marc
|
|
2018
|
78 |
12 |
p. 1229-1246
|
article
|
| 12 |
Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease
|
Fouque, Denis
|
|
2018
|
78 |
12 |
p. 1171-1186
|
article
|
| 13 |
Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option
|
Davis, Mellar P.
|
|
2018
|
78 |
12 |
p. 1211-1228
|
article
|
Journal description